Medication Guide - 7/2/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Keytruda Pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 MERCK SHARP DOHME 07/01/2021 Rituxan Rituximab SOLUTION;INTRAVENOUS 103705 GENENTECH 06/30/2021 Topamax Topiramate TABLET;ORAL 020505 JANSSEN PHARMS 06/30/2021 Topamax Topiramate CAPSULE;ORAL 020844 JANSSEN PHARMS 06/30/2021 Topamax Sprinkle Topiramate CAPSULE;ORAL 020844 JANSSEN PHARMS 06/30/2021 Adhansia XR Methylphenidate Hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 212038 PURDUE PHARMA LP 06/28/2021 Aveed Testosterone Undecanoate INJECTABLE;INTRAMUSCULAR 022219 ENDO PHARMS INC 06/28/2021 Focalin Dexmethylphenidate Hydrochloride TABLET;ORAL 021278 NOVARTIS 06/26/2021 Focalin XR Dexmethylphenidate Hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021802 NOVARTIS 06/26/2021 Ritalin Methylphenidate Hydrochloride TABLET;ORAL 010187 NOVARTIS 06/26/2021 Ritalin LA Methylphenidate Hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284 NOVARTIS 06/26/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA